NCC to initiate new research to develop nationwide Clinical Trial Network, LC-SCRUM-CD (Clinical Development), supported by PREMIA and Paradigm, to further accelerate precision medicine for patients.

 The National Cancer Center (“NCC”), Precision Medicine Asia Co., Ltd. (“PREMIA”) and Paradigm Health Inc (“Paradigm”), announced the initiation of LC-SCRUM-CD (Lung Cancer Genome Screening Project for Individualized Medicine-Clinical Development), a nationwide Clinical Trial Network. This network will leverage the cancer genomic screening network, comprising 150+ LC-SCRUM-Asia hospitals, to promote precision medicine for cancer patients. 

Read the full press release below:

241101_英語最終版【プレスリリース】NCC_PREMIA_Paradigm.pdf

Download PDF • 381KB